SQZ Biotechnologies Company (SQZB)

USD 0.03

(1.82%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018
Revenue 21.47 Million 27.09 Million 20.99 Million 20.1 Million 12.66 Million
Cost of Revenue 11.68 Million 11.03 Million - - -
Gross Profit 9.79 Million 16.06 Million 20.99 Million 20.1 Million 12.66 Million
Operating Expenses 85.61 Million 84.83 Million 61.11 Million 50.01 Million 32 Million
Selling, General and Administrative Expenses 16.13 Million 15.89 Million 9.56 Million 13.91 Million 7.62 Million
Research and Development Expenses 69.48 Million 68.94 Million 51.54 Million 36.1 Million 24.37 Million
Other Expenses - -8000.00 -13 Thousand -7000.00 -
Cost and Expenses 97.3 Million 95.86 Million 72.05 Million 54.37 Million 33.07 Million
Operating Income -75.82 Million -68.76 Million -51.05 Million -34.26 Million -20.4 Million
Interest Expense - - - - 59 Thousand
Income Tax Expense - - - - 984 Thousand
Earnings before Tax -79.46 Million -68.74 Million -50.52 Million -32.2 Million -19.25 Million
Net Income -79.46 Million -68.74 Million -50.52 Million -32.2 Million -20.23 Million
Earnings Per Share Basic -2.76 -2.49 -2.04 -1.31 -0.82
Earnings Per Share Diluted -2.76 -2.49 -2.04 -1.31 -0.82
Weighted Average Shares Outstanding 28.81 Million 27.57 Million 24.78 Million 24.63 Million 24.63 Million
Weighted Average Shares Outstanding (Diluted) 28.81 Million 27.57 Million 24.78 Million 24.63 Million 24.63 Million
Gross Margin 0.46 0.59 1.00 1.00 1.00
EBIT Margin -2.99 -2.13 -1.91 -1.49 -1.53
Profit Margin -3.70 -2.54 -2.41 -1.60 -1.60
EBITDA -64.14 Million -57.73 Million -40.11 Million -29.9 Million -18.18 Million
Earnings Before Tax Margin -3.53 -2.54 -2.43 -1.70 -1.61

Income Statement Charts